Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Some individuals report feeling less interested in food or experiencing earlier satiety when eating
Stronger cardiovascular data: The SELECT trial provides robust evidence for cardiovascular protection
86,4% of subjects in the semaglutide group achieved at least a 5% weight loss, 50,5% at least a 15% weight loss, and 32% at least a 20% weight loss
Those with both type 2 diabetes/obesity and rheumatoid arthritis who are considering GLP-1 therapy should discuss this with both their GP and rheumatologist
CH By Caroline Hudson Medical Devices Philips earnings beat estimates with boost from US tariff refund CH By Charlotte Hughes-Morgan, Bloomberg Politics & Regulation Trump administration demands hospitals share ER records AS By Amanda Seitz, Maia Rosenfeld, and Darius Tahir, KFF Health News Politics & Regulation Why CMS Medicare enrollment crackdown is alarming providers BE By Bridget Early
US$ 27.42
US$ 21.95
US$ 29.74
US$ 20.59
